This document discusses medical device markets and channels. It notes that medical devices generally require physical delivery and direct sales to hospitals, physicians, or patients. Some exceptions include software-based products. It also discusses that building sales and marketing infrastructure for medical devices is very expensive. As alternatives, it suggests targeting key customers of larger companies or pricing based on clinical viability rather than revenue to attract acquirers. Finally, it mentions that medical device gross margins impact the viable distribution methods and exit opportunities.